The Barnett Institute's Dr. Barry Karger and colleagues at the Massachusetts General Hospital Cancer Center have identified a network of genetic markers capable of predicting the relapse of estrogen-receptor positive breast cancer. Dr. Karger teaches in Northeastern's Professional Science Master's in Biotechnology Program. Read more.

For news about the Professional Science Master's degree, go to www.northeastern.edu/biotech/psmnews.html.

For news stories of Northeastern's biotechnology community, see below.

• Dr. Michael Pollastri Discusses Healthcare for Neglected Populations, 5/22/12
• Dr. William Hancock Leads International Effort to MaP Human Genome, 4/30/12 
• Northeastern's Center for Drug Discovery Hosts 10th Annual Symposium on Current Trends in Drug-abuse Research, 4/25/12
• Dr. Günther Zupanc, Biology Chair, Publishes Results in Neuroscience Demonstrating Mechanism by Which New Neurons Find Home, 4/18/12 
• Drs. Mary Jo Ondrechen and Penny Beuning Explore the Possibility of Using Enzymes to Replace Standard Industrial Processes, 4/5/12
• Dr. Alexandros Makriyannis Receives Annual Award in Medicinal Chemistry from the American Chemical Society, 4/2/12
• Dr. Barry Karger and Colleagues at Mass General Hospital Cancer Center Identify Genetic Markers Capable of Predicting the Relapse of ER+ Breast Cancer, 3/16/12
• Dr. Graham Jones, Chair of Northeastern's Dept. of Chemistry and Chemical Biology, Answers Questions about FDA Standards and How the Global Market May Worsen the Problem of Shortages for Certain Drugs, 2/27/12
• Dr. Michael Pollastri Collaborates with the Flatley Discovery Lab to Develop a Cure for Cystic Fibrosis 2/23/12
• Dr. Paul Vouros Forensic Science Collaboration with PhD Student Adam Hall Develops Efficient Method for Characterizing Drug Samples, 2/3/12
• Dr. Michael Pollastri's Research Collaboration Aims to Find Existing Drugs to Stop Sleeping Sickness, 1/20/12
• Northeastern Researchers Explore the Nanotechnology through Innovative Work across Research Centers and Programs, 11/7/11
• Dr. John Engen, Professor of Chemistry and Chemical Biology, Collaborates with Dana-Farber Cancer Institute to Study the Structure of Antibodies that Neutralize HIV Function, 11/2/11
• Third Rock Ventures Co-founder Mark Levin Featured Emphasizes Values at Northeastern's Annual Biotechnology Entrepreneur Lecture Series, 10/27/11
• Northeastern Hosts Top Researchers and Industry Experts to Discuss the Future of Biopharmaceuticals, 10/17/11 
• Dr. William Hancock Leads International Effort to Understand the Human Genome, 10/4/11
• Dr. Mansoor Amiji Targets Tumors with Nanotechnology, 10/3/11
• Northeastern Explores Biotech Collaboration with Algeria, 9/26/11
• Dr. Christopher Austin, scientific director of the NIH’s Center of Translational Therapeutics and senior advisor for the director of translational research at the National Human Genome Research Institute Speaks to Northeastern Community, 9/16/11
• More Articles (archives)